KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1341 |
|---|---|
| Product Name | Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Vanucizumab) |
| Molecular Name | Vanucizumab |
| Alias | Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Vanucizumab |
| CAS Number | 1448221-05-3 |
| Target | ANGPT2 & VEGFA[Homo sapiens], |
| Isotype | VH-C Kappa-CH2-CH3_V Lambda-CH1_H-GAMMA-1_L Kappa |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | WB, FCM, IP, ELISA, Neut, FuncS, IF |
| Buffer | PBS, pH7.5 |
| Background | Vanucizumab (INN, development code RG7221) is an experimental humanized monoclonal antibody designed for the treatment of cancer. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
